isoniazid has been researched along with pyridoxal in 104 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 39 (37.50) | 18.7374 |
1990's | 31 (29.81) | 18.2507 |
2000's | 27 (25.96) | 29.6817 |
2010's | 5 (4.81) | 24.3611 |
2020's | 2 (1.92) | 2.80 |
Authors | Studies |
---|---|
Borová, J; Fuchs, O; Necas, E; Neuwirt, J; Ponka, P | 1 |
Hoy, T; Humphrys, J; Jacobs, A; Ponka, P; Williams, A | 1 |
Borová, J; Fuchs, O; Neuwirt, J; Ponka, P | 1 |
Raje, RR; Shah, PR | 1 |
Matsuda, M; Murakami, Y | 1 |
Callingham, BA; Levene, CI; Sharman, DF | 1 |
Lacave, C; Lanéelle, G; Quémard, A | 1 |
Vidrio, H | 1 |
Brock, JH; Djeha, A | 1 |
Nakornchai, S; Sookvanichsilp, N; Weerapradist, W | 1 |
Campbell, RA; Gale, GR; Jones, MM; Litchenberg, WH; Singh, PK; Smith, AB | 1 |
Eisenstein, RS; Garcia-Mayol, D; Munro, HN; Pettingell, W | 1 |
Baker, E; Richardson, DR | 1 |
Brittenham, GM | 2 |
Chitambar, CR; Zivkovic-Gilgenbach, Z | 1 |
Baker, E; Hefter, GT; May, PM; Richardson, DR; Webb, J | 1 |
Baker, E; Richardson, D; Vitolo, LW; Webb, J | 1 |
Bakkeren, DL; de Jeu-Jaspars, CM; Kroos, MJ; van Eijk, HG | 1 |
Baker, E; Edward, JT; Ponka, P; Richardson, D; Schulman, HM | 1 |
Bakkeren, DL; De Jeu-Jaspars, NM; Kroos, MJ; van Eijk, HG | 1 |
Vitolo, ML; Webb, J | 1 |
Grisham, JW; Sanders, GH; Tsao, MS | 1 |
Clare, BW; Hefter, GT; Vitolo, ML; Webb, J | 1 |
Baker, E; Ponka, P; Richardson, D; Vitolo, ML; Webb, J; Wilairat, P | 1 |
Cheung, E; Sanders, EJ | 1 |
Black, TN; Flynn, TJ; Friedman, L; Klein, NW | 1 |
Andersson, LC; Ekblom, P; Landschulz, W | 1 |
Brock, JH; Stevenson, J | 1 |
Chitambar, CR; Zivkovic, Z | 1 |
Bjelkenkrantz, K; Forsbeck, K; Nilsson, K | 1 |
Finch, CA; Huebers, HA; Kim, BK | 1 |
Ponka, P; Schulman, HM | 1 |
Baker, E; Vitolo, ML; Webb, J | 1 |
Ekblom, P; Landschulz, W | 1 |
Bird, TA; Carrington, MJ; Levene, CI | 1 |
Grady, RW; Ponka, P; Schulman, HM; Wilczynska, A | 1 |
Ekblom, P; Landschulz, W; Thesleff, I | 1 |
Avramovici-Grisaru, S; Hershko, C; Link, G; Sarel, S | 1 |
Huang, AR; Ponka, P | 1 |
Ponka, P; Schulman, HM; Wilczynska, A | 1 |
Avramovici-Grisaru, S; Gelfand, L; Hershko, C; Link, G; Sarel, S | 1 |
Finch, CA; Johnson, DK; Pippard, MJ | 1 |
Cikrt, M; Necas, E; Neuwirt, J; Ponka, P | 1 |
Ponka, P; Richardson, DR; Tran, EH | 1 |
Chubb, FL; Edward, JT; Ponka, P; Richardson, DR | 1 |
Ponka, P; Richardson, DR | 3 |
Crowe, A; Morgan, EH | 1 |
Brown, CS; Heath, TD; Mönkkönen, J; Thompson, TT | 1 |
Bhattacharya, M; Chemtob, S; Hanna, N; Hardy, P; Lachapelle, P; Ponka, P; Varma, DR | 1 |
Milnes, K; Richardson, DR | 1 |
Richardson, DR | 4 |
Connell, E; Hsu, C; Mescher, AL; Overton, B; Patel, C | 1 |
Chubb, FL; Edward, JT; Sangster, J | 1 |
Bláha, K; Cikrt, M; Nerudová, J; Ponka, HF | 1 |
Boon, P; Chitambar, CR; Wereley, JP | 1 |
Hermes-Lima, M; Nagy, E; Ponka, P; Schulman, HM | 1 |
Andrews, M; Hermes-Lima, M; Ponka, P; Santos, NC; Schulman, HM; Yan, J | 1 |
Bernhardt, PV; Richardson, DR | 1 |
Becker, E; Richardson, DR | 1 |
Hermes-Lima, M; Ponka, P; Schulman, HM | 1 |
Chang, SJ | 1 |
Becker, E; Mouralian, C; Ponka, P; Richardson, DR | 1 |
Gao, J; Richardson, DR | 1 |
Castilho, RF; Hermes-Lima, M; Meinicke, AR; Santos, NC | 1 |
Andrade, RG; Gonçalves, MS; Hermes-Lima, M | 1 |
Buss, JL; Neuzil, J; Ponka, P | 2 |
Arduini, E; Buss, JL; Ponka, P | 1 |
Adamcová, M; Gersl, V; Hrdina, R; Klimtová, I; Machácková, J; Pelouch, V; Ponka, P; Simůnek, T | 1 |
Buss, JL; Gellert, N; Neuzil, J; Ponka, P; Weber, C | 1 |
Breuer, W; Cabantchik, ZI; Hershko, C; Konijn, AM; Link, G; Ponka, P | 1 |
Buss, JL; Ponka, P | 1 |
Arduini, E; Buss, JL; Ponka, P; Shephard, KC | 1 |
Buss, JL; Hermes-Lima, M; Ponka, P | 1 |
Alonso, A; Gomes, CS; Hermes-Lima, M; Lopes, GK; Maurício, AQ; Oliveira, RG | 1 |
ASANO, N; YONEDA, M | 1 |
CANAL, N; GARATTINI, S | 1 |
BOONE, IU; ROGERS, BS; STRANG, VG | 1 |
LEVENE, CI | 1 |
GONNARD, P; NGUYEN-PHILIPPON, C | 1 |
CAMIER, M; GONNARD, P | 1 |
Baliharová, V; Gersl, V; Kaiserová, H; Kvasnicková, E; Schröterová, L; Velík, J | 1 |
Klime, J; Kovaríková, P; Mokrý, M; Vávrová, K | 1 |
Adamcová, M; Gersl, V; Hrdina, R; Kaplanová, J; Klimtová, I; Mazurová, Y; Ponka, P; Simůnek, T; Sterba, M | 1 |
Cabantchik, ZI; Hershko, CM; Konijn, AM; Link, GM | 1 |
Klimes, J; Kovaríková, P; Mokrý, M; Vávrová, K | 1 |
Bast, A; den Hartog, GJ; Kaiserová, H; Kvasnicková, E; Schröterová, L; Simůnek, T | 1 |
Kalinowski, DS; Richardson, DR | 1 |
Adamcova, M; Gersl, V; Kaiserova, H; Mazurova, Y; Ponka, P; Popelova, O; Potacova, A; Simunek, T; Sterba, M | 1 |
Klimes, J; Kovaríková, P; Mrkvicková, Z | 1 |
Kalinowski, DS; Klimes, J; Kovaríková, P; Lovejoy, DB; Richardson, DR; Stariat, J | 1 |
Kovacevic, Z; Richardson, DR; Yu, Y | 1 |
Cowley, PM; DeRuisseau, KC; DeRuisseau, LR; Doyle, RP; Fazen, CH; Park, YM | 1 |
Kalinowski, DS; Menezes, SV; Merlot, AM; Pantarat, N; Richardson, DR; Sahni, S | 1 |
Chen, YL; Hider, RC; Kong, X; Xie, Y | 1 |
Brewer, CT; Chen, T; Edwards, A; Lee, RE; Low, J; Lu, Y; Wu, J; Yang, L | 1 |
Chen, L; Rao, Z; Wei, Y; Wen, Y; Wu, X; Zhang, G | 1 |
Chen, J; Lin, X; Lin, Z; Ru, J; Wen, M; Yang, S; Yao, C; Zhang, H; Zhuge, Q | 1 |
8 review(s) available for isoniazid and pyridoxal
Article | Year |
---|---|
Pyridoxal isonicotinoyl hydrazone: an effective iron-chelator after oral administration.
Topics: Administration, Oral; Animals; Double-Blind Method; Drug Evaluation; Drug Evaluation, Preclinical; Humans; Iron Chelating Agents; Isoniazid; Pyridoxal; Randomized Controlled Trials as Topic | 1990 |
Pyridoxal isonicotinoyl hydrazone. Effective iron chelation after oral administration.
Topics: Administration, Oral; Animals; Drug Evaluation; Humans; Iron Chelating Agents; Isoniazid; Pyridoxal; Thalassemia | 1990 |
Pyridoxal isonicotinoyl hydrazone (PIH): a promising new iron chelator.
Topics: Chemical Phenomena; Chemistry; Humans; Iron Chelating Agents; Isoniazid; Pyridoxal | 1988 |
Pyridoxal isonicotinoyl hydrazone and its analogs: potential orally effective iron-chelating agents for the treatment of iron overload disease.
Topics: Animals; Iron Chelating Agents; Iron Overload; Isoniazid; Mice; Pyridoxal; Rats | 1998 |
Analogues of pyridoxal isonicotinoyl hydrazone (PIH) as potential iron chelators for the treatment of neoplasia.
Topics: Animals; Antineoplastic Agents; Biological Transport; Carrier Proteins; Cell Division; Humans; Iron Chelating Agents; Isoniazid; Membrane Proteins; Neoplasms; Pyridoxal | 1998 |
Orally effective iron chelators for the treatment of iron overload disease: the case for a further look at pyridoxal isonicotinoyl hydrazone and its analogs.
Topics: Administration, Oral; Animals; Deferiprone; Ferritins; Iron; Iron Chelating Agents; Iron Overload; Isoniazid; Pyridones; Pyridoxal; Rats; Treatment Outcome | 1998 |
Pyridoxal isonicotinoyl hydrazone and its analogues.
Topics: Animals; Antioxidants; Drug Evaluation, Preclinical; Humans; In Vitro Techniques; Iron; Iron Chelating Agents; Iron Overload; Isoniazid; Molecular Structure; Pyridoxal | 2002 |
Therapeutic potential of iron chelators in cancer therapy.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Deferoxamine; Humans; Iron; Iron Chelating Agents; Isoniazid; Neoplasms; Pyridoxal; Thiosemicarbazones; Tumor Suppressor Protein p53 | 2002 |
3 trial(s) available for isoniazid and pyridoxal
Article | Year |
---|---|
Pyridoxal isonicotinoyl hydrazone: an effective iron-chelator after oral administration.
Topics: Administration, Oral; Animals; Double-Blind Method; Drug Evaluation; Drug Evaluation, Preclinical; Humans; Iron Chelating Agents; Isoniazid; Pyridoxal; Randomized Controlled Trials as Topic | 1990 |
Pyridoxal isonicotinoyl hydrazone. Effective iron chelation after oral administration.
Topics: Administration, Oral; Animals; Drug Evaluation; Humans; Iron Chelating Agents; Isoniazid; Pyridoxal; Thalassemia | 1990 |
Vitamin B6 antagonists alter the function and ultrastructure of mice endothelial cells.
Topics: Animals; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Endothelium, Vascular; Epoprostenol; Isoniazid; Mice; Mice, Inbred ICR; Microscopy, Electron; Pyridoxal; Pyridoxal Phosphate; Pyridoxine; Random Allocation; Vitamin B 6 Deficiency | 2000 |
95 other study(ies) available for isoniazid and pyridoxal
Article | Year |
---|---|
A study of intracellular iron metabolism using pyridoxal isonicotinoyl hydrazone and other synthetic chelating agents.
Topics: Animals; Chelating Agents; Female; Hydrazones; Iron; Iron Chelating Agents; Iron Radioisotopes; Isoniazid; Mice; Mitochondria; Pyridoxal; Rabbits; Reticulocytes | 1979 |
Effective iron chelation following oral administration of an isoniazid-pyridoxal hydrazone.
Topics: Animals; Deferoxamine; Heme; Iron; Iron Chelating Agents; Isoniazid; Liver; Male; Pyridoxal; Pyridoxine; Rats; Spleen | 1979 |
Mobilization of iron from reticulocytes. Identification of pyridoxal isonicotinoyl hydrazone as a new iron chelating agent.
Topics: Animals; Iron; Isoniazid; Kinetics; Pyridoxal; Pyridoxal Phosphate; Rabbits; Reticulocytes; Spectrophotometry | 1979 |
Hydrazones of isoniazid for colorimetric analysis.
Topics: Benzaldehydes; Colorimetry; Hydrazones; Isoniazid; Methods; Pyridoxal; Schiff Bases | 1977 |
The effect of castrix (2-chloro-4- dimethylamino-6-methylpyrimidine) on the distribution of B6 vitamers in mouse brain.
Topics: Aminooxyacetic Acid; Animals; Anticonvulsants; Brain; Isoniazid; Male; Mice; Penicillamine; Pyridoxal; Pyridoxal Phosphate; Pyridoxamine; Pyridoxine; Pyrimidines; Seizures; Semicarbazides | 1976 |
Inhibition of chick embryo lysyl oxidase by various lathyrogens and the antagonistic effect of pyridoxal.
Topics: Aminopropionitrile; Animals; Chick Embryo; Cross-Linking Reagents; Homocysteine; Isoniazid; Penicillamine; Protein-Lysine 6-Oxidase; Pyridoxal; Semicarbazides | 1992 |
Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurum.
Topics: Cell-Free System; Drug Resistance, Microbial; Fatty Acids, Nonesterified; Isoniazid; Mycobacterium; Mycolic Acids; NAD; Peroxidase; Pyridoxal; Pyridoxal Phosphate | 1991 |
Interaction with pyridoxal as a possible mechanism of hydralazine hypotension.
Topics: Anesthesia; Animals; Blood Pressure; Cinnarizine; Dose-Response Relationship, Drug; Hydralazine; Injections, Intraperitoneal; Isoniazid; Male; Pyridoxal; Pyridoxine; Rats; Rats, Inbred Strains; Vasodilator Agents; Verapamil | 1990 |
Uptake and intracellular handling of iron from transferrin and iron chelates by mitogen stimulated mouse lymphocytes.
Topics: Animals; Cells, Cultured; Chelating Agents; Ferric Compounds; Intracellular Fluid; Iron; Iron Chelating Agents; Isoniazid; Lymphocyte Activation; Lymphocytes; Mice; Mice, Inbred BALB C; Nitrilotriacetic Acid; Pyridoxal; Transferrin | 1992 |
Toxicological study of pyridoxal isonicotinoyl hydrazone: acute and subchronic toxicity.
Topics: Administration, Oral; Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Blood Urea Nitrogen; Body Weight; Chelating Agents; Female; Hematocrit; Injections, Intraperitoneal; Isoniazid; Kidney; Lethal Dose 50; Liver; Male; Mice; Pyridoxal; Rats | 1991 |
Comparative iron mobilizing actions of deferoxamine, 1,2-dimethyl-3-hydroxypyrid-4-one, and pyridoxal isonicotinoyl hydrazone in iron hydroxamate-loaded mice.
Topics: Animals; Deferiprone; Deferoxamine; Hydroxamic Acids; Iron; Isoniazid; Male; Mice; Mice, Inbred Strains; Pyridones; Pyridoxal; Tissue Distribution | 1991 |
Regulation of ferritin and heme oxygenase synthesis in rat fibroblasts by different forms of iron.
Topics: Animals; Cell Line; Deferoxamine; Enzyme Induction; Ferritins; Fibroblasts; Heme; Heme Oxygenase (Decyclizing); Iron; Isoniazid; Kinetics; Pyridoxal; Rats | 1991 |
The release of iron and transferrin from the human melanoma cell.
Topics: Antigens, Neoplasm; Cell Line; Deferoxamine; Humans; Iron; Iron Chelating Agents; Isoniazid; Kinetics; Melanoma; Melanoma-Specific Antigens; Neoplasm Proteins; Pyridoxal; Transferrin | 1991 |
Influence of cellular iron status on the release of soluble transferrin receptor from human promyelocytic leukemic HL60 cells.
Topics: Cell Membrane; Chromatography, Gel; Humans; Iron; Isoniazid; Leukemia, Promyelocytic, Acute; Ligands; Pyridoxal; Receptors, Transferrin; Solubility; Tumor Cells, Cultured | 1990 |
Iron chelators of the pyridoxal isonicotinoyl hydrazone class. III. Formation constants with calcium(II), magnesium(II) and zinc(II).
Topics: Calcium; Chelation Therapy; Chemical Phenomena; Chemistry; Humans; Iron Chelating Agents; Isoniazid; Ligands; Magnesium; Pyridoxal; Zinc | 1989 |
Pyridoxal isonicotinoyl hydrazone and analogues. Study of their stability in acidic, neutral and basic aqueous solutions by ultraviolet-visible spectrophotometry.
Topics: Drug Stability; Hydrazones; Hydrogen-Ion Concentration; Hydrolysis; Iron Chelating Agents; Isoniazid; Pyridoxal; Solutions; Spectrophotometry; Spectrophotometry, Ultraviolet | 1989 |
Release of iron from endosomes is an early step in the transferrin cycle.
Topics: Adenosine Triphosphate; Cell Fractionation; Cell Line; Centrifugation; Endocytosis; Endosomes; Humans; Iron; Iron Chelating Agents; Iron Radioisotopes; Isoniazid; Leukemia, Erythroblastic, Acute; Pyridoxal; Transferrin | 1987 |
Effect of pyridoxal isonicotinoyl hydrazone and other hydrazones on iron release from macrophages, reticulocytes and hepatocytes.
Topics: Animals; Hydrazones; Iron; Isoniazid; Liver; Macrophages; Mice; Pyridoxal; Rabbits; Reticulocytes | 1988 |
Characteristics of iron release from isolated heavy and light endosomes.
Topics: Endocytosis; Ethylmaleimide; Humans; Iron; Iron Chelating Agents; Isoniazid; Lactates; Phenanthrolines; Proteins; Pyridoxal; Transferrin; Tumor Cells, Cultured; Uncoupling Agents | 1988 |
Regulation of growth of cultured hepatic epithelial cells by transferrin.
Topics: Animals; Blood; Cell Division; Cell Line; Chelating Agents; Culture Media; Cycloheximide; DNA; Epidermal Growth Factor; Epithelial Cells; Epithelium; Insulin; Interphase; Isoniazid; Liver; Pyridoxal; Rats; Transferrin | 1987 |
Chemical studies of pyridoxal isonicotinoyl hydrazone relevant to its clinical evaluation.
Topics: Chemical Phenomena; Chemistry; Ferritins; Iron; Iron Chelating Agents; Isoniazid; Pyridoxal | 1988 |
Effect of pyridoxal isonicotinoyl hydrazone and analogs on iron metabolism in hepatocytes and macrophages in culture.
Topics: Animals; Cells, Cultured; Iron; Iron Chelating Agents; Isoniazid; Liver; Macrophages; Pyridoxal; Rats; Transferrin | 1988 |
Transferrin and iron requirements of embryonic mesoderm cells cultured in hydrated collagen matrices.
Topics: Actins; Animals; Antibodies; Cell Aggregation; Cell Division; Cells, Cultured; Chick Embryo; Collagen; Fibroblasts; Iron; Iron Chelating Agents; Isoniazid; Mesoderm; Microscopy, Electron; Muscles; Pyridoxal; Transferrin | 1988 |
Methionine and iron as growth factors for rat embryos cultured in canine serum.
Topics: Animals; Blood; Culture Media; Dogs; Growth Substances; Iron Chelating Agents; Isoniazid; Male; Methionine; Organ Culture Techniques; Pyridoxal; Rats; Transferrin | 1987 |
A lipophilic iron chelator induces an enhanced proliferation of human erythroleukaemia (HEL) cells.
Topics: Cell Cycle; Cell Line; Chelating Agents; Humans; Iron; Iron Chelating Agents; Isoniazid; Leukemia, Erythroblastic, Acute; Pyridoxal; Transferrin | 1986 |
Replacement of transferrin in serum-free cultures of mitogen-stimulated mouse lymphocytes by a lipophilic iron chelator.
Topics: Animals; Culture Media; Iron Chelating Agents; Isoniazid; Lymphocyte Activation; Lymphocytes; Mice; Pyridoxal; Transferrin | 1987 |
Inhibition of hemoglobin production by transferrin-gallium.
Topics: Anemia, Hypochromic; Animals; Cell Division; Cell Line; Cytarabine; Dimethyl Sulfoxide; Erythropoiesis; Gallium; Hemoglobins; Iron; Isoniazid; Mice; Pyridoxal; Receptors, Transferrin; Transferrin | 1987 |
Role of iron in the proliferation of the established human tumor cell lines U-937 and K-562: effects of suramin and a lipophilic iron chelator (PIH).
Topics: Cell Cycle; Cell Division; Cell Line; DNA; Humans; Intracellular Membranes; Iron; Iron Chelating Agents; Isoniazid; Neoplasms; Pyridoxal; Receptors, Transferrin; Suramin; Transferrin | 1986 |
Effectiveness of oral iron chelators assayed in the rat.
Topics: Administration, Oral; Animals; Deferoxamine; Female; Ferritins; Iron Chelating Agents; Isoniazid; Male; Pyridoxal; Rats; Rats, Inbred Strains | 1987 |
Regulation of heme synthesis in erythroid cells: hemin inhibits transferrin iron utilization but not protoporphyrin synthesis.
Topics: 2,2'-Dipyridyl; Animals; Erythrocytes; Glycine; Heme; Heptanoates; Iron; Isoniazid; Porphyrins; Protoporphyrins; Pyridoxal; Rabbits; Reticulocytes; Transferrin | 1985 |
Iron chelation by pyridoxal isonicotinoyl hydrazone and analogues in hepatocytes in culture.
Topics: Animals; Cells, Cultured; Chelating Agents; Deferoxamine; Iron; Isoniazid; Liver; Male; Pyridoxal; Rats; Rats, Inbred Strains; Transferrin | 1985 |
Iron delivery during proliferation and differentiation of kidney tubules.
Topics: Animals; Cell Differentiation; Cell Division; Female; Hemin; Iron; Isoniazid; Kidney Tubules; Mice; Molecular Weight; Organ Culture Techniques; Pregnancy; Protoporphyrins; Pyridoxal; Transferrin | 1985 |
The inhibition of lysyl oxidase in vivo by isoniazid and its reversal by pyridoxal. Effect on collagen cross-linking in the chick embryo.
Topics: Amino Acid Oxidoreductases; Animals; Bone and Bones; Cartilage; Chick Embryo; Collagen; Cycloheximide; Hydroxyproline; Isoniazid; Liver; Protein-Lysine 6-Oxidase; Pyridoxal; Pyridoxal Phosphate | 1984 |
The effect of various chelating agents on the mobilization of iron from reticulocytes in the presence and absence of pyridoxal isonicotinoyl hydrazone.
Topics: 2,2'-Dipyridyl; Animals; Chelating Agents; Globins; Hydrogen-Ion Concentration; Iron; Isoniazid; Phenanthrolines; Pyridoxal; Rabbits; Reticulocytes; Spectrophotometry | 1984 |
A lipophilic iron chelator can replace transferrin as a stimulator of cell proliferation and differentiation.
Topics: Animals; Cell Differentiation; Cell Division; DNA Replication; Embryo, Mammalian; Female; Iron Chelating Agents; Isoniazid; Kidney; Kidney Tubules; Kinetics; Mice; Mice, Inbred Strains; Organ Culture Techniques; Pregnancy; Pyridoxal; Transferrin | 1984 |
Syntheses of iron bis(pyridoxal isonicotinoylhydrazone)s and the in vivo iron-removal properties of some pyridoxal derivatives.
Topics: Animals; Chelating Agents; Hydrogen-Ion Concentration; Iron; Isoniazid; Kinetics; Liver; Magnetic Resonance Spectroscopy; Pyridoxal; Rats; Spectrophotometry, Infrared; Spleen; Structure-Activity Relationship | 1983 |
A study of the mechanism of action of pyridoxal isonicotinoyl hydrazone at the cellular level using reticulocytes loaded with non-heme 59Fe.
Topics: Animals; Binding Sites; Chelating Agents; In Vitro Techniques; Iron; Isoniazid; Male; Microtubules; Mitochondria; Oxidation-Reduction; Pyridoxal; Rabbits; Reticulocytes | 1983 |
Ferric pyridoxal isonicotinoyl hydrazone can provide iron for heme synthesis in reticulocytes.
Topics: Animals; Ferric Compounds; Heme; Iron; Iron Chelating Agents; Isoniazid; Kinetics; Pyridoxal; Rabbits; Reticulocytes; Transferrin | 1982 |
Mechanism of in vivo iron chelation by pyridoxal isonicotinoyl hydrazone and other imino derivatives of pyridoxal.
Topics: Animals; Dose-Response Relationship, Drug; Female; Iron; Iron Chelating Agents; Iron Radioisotopes; Isoniazid; Pyridoxal; Rats | 1981 |
A rapid assay for evaluation of iron-chelating agents in rats.
Topics: Animals; Bile; Deferoxamine; Female; Ferritins; Injections, Intravenous; Iron; Iron Chelating Agents; Iron Radioisotopes; Isoniazid; Liver; Male; Pyridoxal; Rats; Rats, Inbred Strains; Time Factors | 1981 |
Biliary iron excretion in rats following pyridoxal isonicotinoyl hydrazone.
Topics: Animals; Bile; Bile Ducts; Chelating Agents; Feces; Female; Hot Temperature; Iron; Isoniazid; Pyridoxal; Rats | 1980 |
The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents.
Topics: Antineoplastic Agents; Biological Transport, Active; Cell Division; Deferoxamine; Gallium; Humans; Iron; Iron Chelating Agents; Isoniazid; Pyridoxal; Transferrin; Tumor Cells, Cultured | 1995 |
Iron chelators of the pyridoxal isonicotinoyl hydrazone class. Relationship of the lipophilicity of the apochelator to its ability to mobilise iron from reticulocytes in vitro.
Topics: Animals; Chemical Phenomena; Chemistry, Physical; Chromatography, Thin Layer; In Vitro Techniques; Iron; Iron Chelating Agents; Iron Radioisotopes; Isoniazid; Lipids; Pyridoxal; Rabbits; Reticulocytes | 1994 |
The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis.
Topics: Deferoxamine; DNA; Humans; Iron; Iron Chelating Agents; Isoniazid; Neuroblastoma; Osmolar Concentration; Pyridoxal; Thymidine; Transferrin; Tumor Cells, Cultured | 1994 |
Effects of chelators on iron uptake and release by the brain in the rat.
Topics: 2,2'-Dipyridyl; Aging; Animals; Biological Transport; Bone and Bones; Brain; Deferiprone; Deferoxamine; Female; Iron; Iron Chelating Agents; Iron Radioisotopes; Isoniazid; Kidney; Liver; Male; Pentetic Acid; Pyridones; Pyridoxal; Rats; Rats, Wistar | 1994 |
Liposome-mediated delivery of gallium to macrophage-like cells in vitro: demonstration of a transferrin-independent route for intracellular delivery of metal ions.
Topics: Ammonium Chloride; Animals; Cell Line; Chlorocebus aethiops; Drug Compounding; Drug Delivery Systems; Endocytosis; Gallium; Hemin; Iron Chelating Agents; Isoniazid; Liposomes; Macrophages; Melanoma; Metals; Mice; Nitrilotriacetic Acid; Pyridoxal; Transferrin; Tumor Cells, Cultured | 1993 |
Prevention of postasphyxia electroretinal dysfunction with a pyridoxal hydrazone.
Topics: Animals; Animals, Newborn; Asphyxia Neonatorum; Deferoxamine; Disease Models, Animal; Electroretinography; Humans; Hydrogen Peroxide; Infant, Newborn; Iron Chelating Agents; Isoniazid; Malondialdehyde; Oxidative Stress; Peroxides; Pyridoxal; Retina; Swine; Vision Disorders | 1997 |
The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone.
Topics: Antineoplastic Agents; Apoptosis; Benzaldehydes; Cell Cycle; Cell Division; Deferoxamine; DNA Fragmentation; Drug Design; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Ferritins; Growth Inhibitors; HL-60 Cells; Humans; Hydrazones; Iron; Iron Chelating Agents; Isoniazid; Ligands; Molecular Structure; Naphthols; Neoplasm Proteins; Neoplasms; Pyridoxal; Structure-Activity Relationship; Transferrin; Tumor Cells, Cultured | 1997 |
Mobilization of iron from neoplastic cells by some iron chelators is an energy-dependent process.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Cell Membrane; CHO Cells; Cricetinae; Iron; Iron Chelating Agents; Iron Radioisotopes; Isoniazid; Pyridoxal; Temperature; Tumor Cells, Cultured | 1997 |
Cytotoxic analogs of the iron(III) chelator pyridoxal isonicotinoyl hydrazone: effects of complexation with copper(II), gallium(III), and iron (III) on their antiproliferative activities.
Topics: Antineoplastic Agents; Copper; Ferric Compounds; Gallium; Humans; Iron Chelating Agents; Isoniazid; Pyridoxal | 1997 |
Transferrin is necessary and sufficient for the neural effect on growth in amphibian limb regeneration blastemas.
Topics: Ambystoma; Animals; Antibodies; Brain; Cell Division; Cell Extracts; Extremities; Iron; Iron Chelating Agents; Isoniazid; Liver; Nerve Tissue Proteins; Organ Culture Techniques; Peripheral Nerves; Pyridoxal; Regeneration; RNA, Messenger; Thymidine; Transferrin | 1997 |
Iron chelators of the pyridoxal isonicotinoyl hydrazone class. Relationship of the lipophilicity of the apochelator to its ability to mobilize iron from reticulocytes in vitro: reappraisal of reported partition coefficients.
Topics: Iron; Iron Chelating Agents; Isoniazid; Models, Chemical; Pyridoxal; Reticulocytes | 1997 |
Biliary iron excretion in rats following treatment with analogs of pyridoxal isonicotinoyl hydrazone.
Topics: Animals; Bile; Female; Iron; Iron Chelating Agents; Isoniazid; Pyridoxal; Rats; Rats, Wistar | 1998 |
Evaluation of transferrin and gallium-pyridoxal isonicotinoyl hydrazone as potential therapeutic agents to overcome lymphoid leukemic cell resistance to gallium nitrate.
Topics: Antineoplastic Agents; Cell Division; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Gallium; Humans; Isoniazid; Leukemia, Lymphoid; Pyridoxal; Transferrin; Tumor Cells, Cultured | 1996 |
The iron chelator pyridoxal isonicotinoyl hydrazone (PIH) protects plasmid pUC-18 DNA against *OH-mediated strand breaks.
Topics: Antioxidants; DNA Damage; Ferrous Compounds; Hydroxyl Radical; Hypoxanthine; Iron Chelating Agents; Isoniazid; Oxidation-Reduction; Plasmids; Pyridoxal; Xanthine Oxidase | 1998 |
EPR spin trapping and 2-deoxyribose degradation studies of the effect of pyridoxal isonicotinoyl hydrazone (PIH) on *OH formation by the Fenton reaction.
Topics: Cyclic N-Oxides; Deoxyribose; Electron Spin Resonance Spectroscopy; Hydrogen Peroxide; Hydroxyl Radical; Iron; Isoniazid; Oxidation-Reduction; Pyridoxal; Spin Trapping | 1999 |
Crystal and molecular structure of 2-hydroxy-1-naphthaldehyde isonicotinoyl hydrazone (NIH) and its iron(III) complex: an iron chelator with anti-tumour activity.
Topics: Antineoplastic Agents; Cell Division; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Electrochemistry; Humans; Iron; Iron Chelating Agents; Isoniazid; Models, Molecular; Neuroectodermal Tumors, Primitive, Peripheral; Pyridoxal; Structure-Activity Relationship; Temperature; Tumor Cells, Cultured | 1999 |
Development of novel aroylhydrazone ligands for iron chelation therapy: 2-pyridylcarboxaldehyde isonicotinoyl hydrazone analogs.
Topics: Biological Transport, Active; Cell Cycle; Cell Division; Cell Line; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Drug Design; GADD45 Proteins; Gene Expression; Humans; Hydrazones; Intracellular Signaling Peptides and Proteins; Iron; Iron Chelating Agents; Isoniazid; Leucine; Ligands; Proteins; Pyridoxal; RNA; Thymidine; Transferrin; Uridine | 1999 |
The iron chelator pyridoxal isonicotinoyl hydrazone (PIH) and its analogues prevent damage to 2-deoxyribose mediated by ferric iron plus ascorbate.
Topics: Ascorbic Acid; Chelating Agents; Deoxyribose; Dimethyl Sulfoxide; DNA Damage; Edetic Acid; Ferric Compounds; Free Radical Scavengers; Hydroxyl Radical; Isoniazid; Kinetics; Models, Chemical; Plasmids; Pyridoxal; Structure-Activity Relationship | 2000 |
Development of potential iron chelators for the treatment of Friedreich's ataxia: ligands that mobilize mitochondrial iron.
Topics: Animals; Drug Design; Friedreich Ataxia; Iron; Iron Chelating Agents; Iron Radioisotopes; Isoniazid; Ligands; Mice; Mitochondria; Molecular Structure; Phenylhydrazines; Pyridoxal; Reticulocytes | 2001 |
The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents, IV: The mechanisms involved in inhibiting cell-cycle progression.
Topics: Antineoplastic Agents; Cell Cycle; Cyclins; Deferoxamine; Female; Genes, Retinoblastoma; Humans; Hydroxyurea; Iron; Iron Chelating Agents; Isoniazid; Pyridoxal; Structure-Activity Relationship; Tumor Cells, Cultured | 2001 |
The iron chelator pyridoxal isonicotinoyl hydrazone inhibits mitochondrial lipid peroxidation induced by Fe(II)-citrate.
Topics: Animals; Antioxidants; Chelating Agents; Ferric Compounds; In Vitro Techniques; Indicators and Reagents; Iron; Iron Chelating Agents; Isoniazid; Lipid Peroxidation; Membrane Potentials; Mitochondria, Liver; Oxidation-Reduction; Oxygen Consumption; Pyridoxal; Rats; Thiobarbituric Acid Reactive Substances | 2001 |
Pyridoxal isonicotinoyl hydrazone (PIH) prevents copper-mediated in vitro free radical formation.
Topics: Ascorbic Acid; Copper Sulfate; Deoxyribose; Free Radical Scavengers; Free Radicals; Hydroxyl Radical; In Vitro Techniques; Iron Chelating Agents; Isoniazid; Kinetics; Oxidation-Reduction; Oxygen; Pyridoxal | 2001 |
The role of oxidative stress in the toxicity of pyridoxal isonicotinoyl hydrazone (PIH) analogues.
Topics: Ascorbic Acid; Cell Survival; Chelating Agents; Drug Design; Humans; Iron Chelating Agents; Isoniazid; Jurkat Cells; K562 Cells; Kinetics; Molecular Structure; Oxidation-Reduction; Oxidative Stress; Pyridoxal; Structure-Activity Relationship | 2002 |
Mobilization of intracellular iron by analogs of pyridoxal isonicotinoyl hydrazone (PIH) is determined by the membrane permeability of the iron-chelator complexes.
Topics: Animals; Biological Transport; Cell Membrane Permeability; In Vitro Techniques; Iron; Iron Chelating Agents; Isoniazid; Mice; Pyridoxal; Reticulocytes; Serum Albumin, Bovine; Structure-Activity Relationship | 2002 |
Cardiac troponin T following repeated administration of pyridoxal isonicotinoyl hydrazone in rabbits.
Topics: Animals; Cell Fractionation; Cytosol; Iron Chelating Agents; Iron Overload; Isoniazid; Male; Myocardium; Myofibrils; Pyridoxal; Rabbits; Troponin T | 2002 |
Pyridoxal isonicotinoyl hydrazone analogs induce apoptosis in hematopoietic cells due to their iron-chelating properties.
Topics: Apoptosis; Ferric Compounds; Hematopoietic Stem Cells; Humans; Iron; Iron Chelating Agents; Isoniazid; Jurkat Cells; K562 Cells; Mitochondria; Pyridoxal; Reticulocytes | 2003 |
Effects of combined chelation treatment with pyridoxal isonicotinoyl hydrazone analogs and deferoxamine in hypertransfused rats and in iron-loaded rat heart cells.
Topics: Animals; Animals, Newborn; Blood Transfusion; Cells, Cultured; Deferoxamine; Female; Ferritins; Heart; Iron; Iron Chelating Agents; Iron Radioisotopes; Isoniazid; Kinetics; Pyridoxal; Rats; Rats, Wistar | 2003 |
Hydrolysis of pyridoxal isonicotinoyl hydrazone and its analogs.
Topics: Animals; Cations; Cell Survival; Cells, Cultured; Drug Design; Half-Life; Hydrogen-Ion Concentration; Hydrolysis; Inhibitory Concentration 50; Iron; Iron Chelating Agents; Isoniazid; Mice; Molecular Structure; Pyridoxal; Reticulocytes; Time Factors | 2003 |
Lipophilicity of analogs of pyridoxal isonicotinoyl hydrazone (PIH) determines the efflux of iron complexes and toxicity in K562 cells.
Topics: Antineoplastic Agents; Biological Transport; Cell Division; Humans; Iron; Iron Chelating Agents; Isoniazid; K562 Cells; Pyridoxal | 2003 |
Pyridoxal isonicotinoyl hydrazone inhibits iron-induced ascorbate oxidation and ascorbyl radical formation.
Topics: Ascorbic Acid; Chelating Agents; Deoxyribose; Edetic Acid; Electron Spin Resonance Spectroscopy; Ferric Compounds; Free Radicals; Hydroxyl Radical; Isoniazid; Nitrilotriacetic Acid; Oxidation-Reduction; Oxidative Stress; Pyridoxal | 2003 |
Competitive action of isonicotinic acid hydrazide and pyridoxal in the amino acid decarboxylation of Escherichia coli.
Topics: Amino Acids; Biochemical Phenomena; Decarboxylation; Escherichia coli; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Pyridoxal; Vitamin B 6 | 1953 |
Isonicotinyl-hydrazide, hepatic respiratory quotient and inhibition of some enzymatic systems with pyridoxal coenzyme.
Topics: Anti-Bacterial Agents; Coenzymes; Enzymes; Isoniazid; Liver; Pyridoxal | 1957 |
Effect of pyridoxal on uptake of C14-activity from labeled isoniazid by Mycobacterium tuberculosis.
Topics: Isoniazid; Mycobacterium tuberculosis; Pyridoxal; Vitamin B 6 | 1957 |
The lathyrogenic effect of isonicotinic acid hydrazide (INAH) on the chick embryo and its reversal by pyridoxal.
Topics: Aminopropionitrile; Animals; Bone and Bones; Chick Embryo; Collagen; Embryo, Mammalian; Embryo, Nonmammalian; Isoniazid; Lathyrism; Pyridoxal; Vitamin B 6 | 1961 |
[SPECTRAL STUDY OF THE BINDING OF PYRIDOXAL-5'-PHOSPHATE ISONICOTINOYLHYDRAZONE TO ASPARTIC-GLUTAMIC APO-TRANSAMINASE].
Topics: Aspartate Aminotransferases; Isoniazid; Isonicotinic Acids; Phosphates; Pyridoxal; Pyridoxal Phosphate; Research; Spectrum Analysis | 1964 |
[STUDY ON THE STABILITY OF 5'-PHOSPHOPYRIDOXAL ISONICOTINOYLHYDRAZONE IN THE PRESENCE OF PYRIDOXAL ENZYMES].
Topics: Aspartate Aminotransferases; Carboxy-Lyases; Chromatography; Glutamates; Isoniazid; Manometry; Pyridoxal; Pyridoxal Phosphate; Research | 1964 |
Oxidative stress mediates toxicity of pyridoxal isonicotinoyl hydrazone analogs.
Topics: Apoptosis; Arachidonic Acids; Buthionine Sulfoximine; Cell Survival; Dose-Response Relationship, Drug; Ferric Compounds; Ferrozine; Glutathione; Humans; Inhibitory Concentration 50; Iron Chelating Agents; Isoniazid; Jurkat Cells; K562 Cells; Lipid Peroxidation; Oxidation-Reduction; Oxidative Stress; Oxygen; Pyridoxal | 2004 |
The effect of new lipophilic chelators on the activities of cytosolic reductases and P450 cytochromes involved in the metabolism of anthracycline antibiotics: studies in vitro.
Topics: Aldehydes; Animals; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Cells, Cultured; Chelating Agents; Cytochrome P-450 Enzyme System; Cytosol; Dose-Response Relationship, Drug; Enzyme Activation; Hepatocytes; Hydrazones; Isoniazid; Male; Oxidoreductases; Pyridoxal; Rabbits | 2004 |
Chromatographic methods for the separation of biocompatible iron chelators from their synthetic precursors and iron chelates.
Topics: Aldehydes; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Hydrazones; Iron Chelating Agents; Isoniazid; Pyridoxal | 2004 |
Study of daunorubicin cardiotoxicity prevention with pyridoxal isonicotinoyl hydrazone in rabbits.
Topics: Animals; Cardiotonic Agents; Daunorubicin; Heart Ventricles; Isoniazid; Male; Myocardium; Pyridoxal; Rabbits | 2005 |
Iron chelation therapy.
Topics: Administration, Oral; Benzoates; beta-Thalassemia; Chelation Therapy; Chemical and Drug Induced Liver Injury; Deferasirox; Deferiprone; Deferoxamine; Drug Therapy, Combination; Humans; Infusions, Intravenous; Iron Chelating Agents; Iron Overload; Isoniazid; Pyridones; Pyridoxal; Survival; Triazoles | 2005 |
HPLC study on stability of pyridoxal isonicotinoyl hydrazone.
Topics: Calibration; Chemistry Techniques, Analytical; Chemistry, Pharmaceutical; Chromatography; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Hydrazones; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Iron; Iron Chelating Agents; Isoniazid; Kinetics; Models, Chemical; Oxygen; Pyridoxal; Solvents; Temperature; Time Factors; Ultraviolet Rays | 2006 |
Iron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin.
Topics: Aldehydes; Antibiotics, Antineoplastic; Apoptosis; Bleomycin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deferoxamine; Doxorubicin; Electron Spin Resonance Spectroscopy; Free Radicals; Humans; Hydrazones; Hydrogen Peroxide; Iron; Iron Chelating Agents; Iron Compounds; Isoniazid; Lipid Peroxidation; Lung Neoplasms; Oxidative Stress; Pyridoxal; Razoxane; Time Factors | 2006 |
Future of toxicology--iron chelators and differing modes of action and toxicity: the changing face of iron chelation therapy.
Topics: Chelation Therapy; Humans; Hydrazones; Iron Chelating Agents; Iron Overload; Isoniazid; Pyridines; Pyridoxal; Structure-Activity Relationship; Thiosemicarbazones; Toxicology | 2007 |
Pyridoxal isonicotinoyl hydrazone (PIH) and its analogs as protectants against anthracycline-induced cardiotoxicity.
Topics: Animals; Antibiotics, Antineoplastic; Cardiotonic Agents; Daunorubicin; Heart Diseases; Iron Chelating Agents; Isoniazid; Pyridoxal; Rabbits | 2008 |
Investigation of the stability of aromatic hydrazones in plasma and related biological material.
Topics: Aldehydes; Animals; Buffers; Cattle; Chromatography, High Pressure Liquid; Culture Media; Drug Stability; Half-Life; Hemofiltration; Hydrazones; Hydrogen-Ion Concentration; Iron Chelating Agents; Isoniazid; Molecular Structure; Phosphates; Pyridoxal; Rabbits; Serum Albumin, Bovine; Temperature | 2008 |
HPLC methods for determination of two novel thiosemicarbazone anti-cancer drugs (N4mT and Dp44mT) in plasma and their application to in vitro plasma stability of these agents.
Topics: Analysis of Variance; Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Data Interpretation, Statistical; Drug Stability; Humans; Isoniazid; Naphthalenes; Pyridoxal; Rabbits; Reproducibility of Results; Sensitivity and Specificity; Swine; Thiosemicarbazones | 2009 |
Chelators to the rescue: different horses for different courses!
Topics: Aldehydes; Animals; Deferoxamine; Humans; Hydrazones; Iron Chelating Agents; Iron Overload; Isoniazid; Myocardial Reperfusion Injury; Neoplasms; Pyridines; Pyridoxal; Rats; Reactive Oxygen Species; Thiosemicarbazones | 2011 |
Aging-related changes in the iron status of skeletal muscle.
Topics: Aging; Animals; Cation Transport Proteins; Ferritins; Gene Expression; Heme; Iron; Iron Chelating Agents; Iron Regulatory Protein 1; Iron Regulatory Protein 2; Isoniazid; Male; Muscle Contraction; Muscle, Skeletal; Muscular Atrophy; Pyridoxal; Rats; Rats, Inbred BN; Rats, Inbred F344; Receptors, Transferrin; RNA, Messenger; Sarcopenia | 2013 |
Cellular uptake of the antitumor agent Dp44mT occurs via a carrier/receptor-mediated mechanism.
Topics: Animals; Antineoplastic Agents; Binding Sites; Biological Transport; Carbon Radioisotopes; Carrier Proteins; Cell Line, Tumor; Cell Membrane; Chelating Agents; Coordination Complexes; Copper; Endocytosis; Female; Heterografts; Humans; Iron; Isoniazid; Mice; Mice, Inbred BALB C; Mice, Nude; Pyridoxal; Temperature; Thiosemicarbazones | 2013 |
The interaction of pyridoxal isonicotinoyl hydrazone (PIH) and salicylaldehyde isonicotinoyl hydrazone (SIH) with iron.
Topics: Aldehydes; Ascorbic Acid; Edetic Acid; Electrochemical Techniques; Electrodes; Ferric Compounds; Ferrous Compounds; Hydrazones; Hydrogen-Ion Concentration; Iron Chelating Agents; Isoniazid; Kinetics; Oxidation-Reduction; Pyridoxal | 2018 |
The Isoniazid Metabolites Hydrazine and Pyridoxal Isonicotinoyl Hydrazone Modulate Heme Biosynthesis.
Topics: 5-Aminolevulinate Synthetase; Animals; Carcinoma, Hepatocellular; Ferrochelatase; Heme; Hep G2 Cells; Hepatocytes; Humans; Hydrazines; Iron; Isoniazid; Liver; Mice, Inbred C57BL; Mice, Transgenic; Protoporphyrins; Pyridoxal; Rifampin; Vitamin B 6 | 2019 |
Pyridoxal isonicotinoyl hydrazone inhibition of FXR is involved in the pathogenesis of isoniazid-induced liver injury.
Topics: Animals; Apoptosis; Behavior, Animal; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Fatty Liver; Gene Expression Regulation; Hepatocytes; Humans; Isoniazid; Male; Models, Molecular; Necrosis; Protein Conformation; Pyridoxal; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; RNA, Messenger | 2020 |
Pyridoxal Isonicotinoyl Hydrazone Improves Neurological Recovery by Attenuating Ferroptosis and Inflammation in Cerebral Hemorrhagic Mice.
Topics: Animals; Apoptosis; Cell Death; Cerebral Hemorrhage; Ferric Compounds; Ferroptosis; Inflammation; Iron; Iron Chelating Agents; Isoniazid; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Neurons; Pyridoxal | 2021 |